Home
About us
Pronova BioPharma in brief
Production facilities
History
Our business concept
Vision, values and strategy
Ethical guidlines
Health, safety and environment
Human resources
Management team
Board of directors
Product
Omacor/Lovaza
Production process
Market
Distribution and partners
Research & development
Approach to R&D
R&D programs
Quality
Ensuring excellent quality
Quality Control
Quality Assurance
Audit programs
Pharmacovigilance
News
Press releases archive
Media
Media contact
Fact sheet
Fact sheet in Norwegian
Photo archive
Investors
The share
Stock market announcements
Reports and presentations
Financial calendar
Shareholder information
Top 20 shareholders
Policies
Dividend policy
Investor relations policy
Articles of association
General meeting
Registrar
Corporate governance
Analytical coverage
Subscribe
Contact information IR
Careers
General application
What we offer
Meet some of our people
Vacancies
Contact
Contact details
Henvendelser om Omacor i Norge
You are here:
Home
/
Media
Media contact
For any enquiries from media, please contact:
Hamed Brodersen
Vice president investor relations (IR) and communications
Tel:
+47 22 53 48 60
Mob:
+47 40 46 81 10
E-mail:
hamed.brodersen@pronova.com
Print
Copyright 2007
©
Pronova BioPharma ASA
idium
web publishing